| Bioactivity | NBI-961 is a potent NEK2 inhibitor that inhibits proteasomal degradation. NBI-961 induces G2/mitosis arrest and apoptosis in diffuse large B cell lymphoma (DLBCL) cells[1]. |
| Name | NBI-961 |
| CAS | 2225902-98-5 |
| Formula | C28H27F3N6O2S |
| Molar Mass | 568.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mason McCrury, et al. Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma. Mol Cancer Ther. 2023 Oct 11. |
NBI-961
CAS: 2225902-98-5 F: C28H27F3N6O2S W: 568.61
NBI-961 is a potent NEK2 inhibitor that inhibits proteasomal degradation. NBI-961 induces G2/mitosis arrest and apoptosi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.